SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarillion Plc Regulatory News (CLLN)

  • This share is currently suspended. It was suspended at a price of 14.27

Share Price Information for Carillion Plc (CLLN)

Share Price is delayed by 15 minutes
Get Live Data
14.27    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £61.40m
CLLN Live PriceLast checked at - London Stock Exchange

Intraday Carillion Plc Share Chart

Disposal

31 Oct 2017 07:00

RNS Number : 0643V
Carillion PLC
31 October 2017
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE

31 October 2017

 

Carillion plc ("Carillion" or the "Group")

£13.8 million disposal of interests in Ask Real Estate

 

The Board of Carillion today announces the disposal of the Group's:

 

(i) 66.67% shareholding in Ask Real Estate Limited ("AREL"), and a shareholder loan made by Carillion Construction Limited to AREL's subsidiary, Ask Central Limited; and

(ii) 50% interest in Ask Carillion Developments LLP ("ACD"),

 

to one or more wholly owned subsidiaries of Dukehill Limited ("Dukehill"), for aggregate cash consideration of £13,800,000 (the "Transaction"). £1,000,000 of the cash consideration is contingent on the sale of 100 Embankment and will be paid by Dukehill within 5 business days of signing of the sale documentation in relation to this.

 

AREL and ACD (through their wholly owned subsidiaries and other associated entities) carry out commercial property development activities, together with various partners, in the North of the UK, including Manchester, Liverpool and Leeds.

 

For the 2016 Financial Year, the interests that are the subject of the Transaction contributed £4.1 million of revenue, £11.6 million profit before tax, and £19.2 million gross assets as at 31 December 2016. The contribution to profit from Carillion's interests in AREL and ACD can vary significantly from year to year. The transaction is expected to generate a modest profit on disposal, and the interests being sold were not expected to make a material contribution to overall Group profit for 2017.

 

The transaction consideration will be applied in reducing the Group's overall leverage position and, following the Transaction, AREL will be deconsolidated from the Group's accounts. AREL managing director, John Hughes and finance director, Jonathan Cross, who together own 33.33% of AREL, will retain their executive positions.

 

Commenting, Keith Cochrane, Interim Chief Executive, said:

'We are pleased to be able to announce further progress. Much remains to be done, and we are continuing to execute our plans to refocus the business, reduce cost and strengthen our balance sheet.'

 

The person responsible for the release of this announcement on behalf of Carillion plc is Westley Maffei.

Enquiries:

Investors/ Analysts:

Carillion plc

Kellie McAvoy, Head of Investor Relations +44 (0) 1902 906333

John Denning, Director Group Corporate Affairs

 

 

Media:

Teneo Blue Rubicon +44 (0) 207 420 3197

Charles Armitstead / Haya Herbert-Burns

 

This and other Carillion news releases can be found at www.carillion.plc 

Cautionary statement

This announcement may contain indications of likely future developments and other forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and business segments in which the Group operates. These and other factors could adversely affect the Group's results, strategy and prospects. Forward-looking statements involve risks, uncertainties and assumptions. They relate to events and/or depend on circumstances in the future which could cause actual results and outcomes to differ materially from those currently anticipated. No obligation is assumed to update any forward-looking statements, whether as a result of new information, future events or otherwise.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUAVNRBAARORA
Date   Source Headline
13th Jul 20174:30 pmRNSHolding(s) in Company
13th Jul 20174:02 pmRNSHolding(s) in Company
13th Jul 20179:25 amRNSHolding(s) in Company
13th Jul 20179:22 amRNSHolding(s) in Company
10th Jul 20177:00 amRNSDirectorate Change
10th Jul 20177:00 amRNSTrading Statement
6th Jul 20174:58 pmRNSHolding(s) in Company
30th Jun 201711:08 amRNSDirectorate Change
19th Jun 20179:07 amRNSBlock listing Interim Review
16th Jun 20174:25 pmRNSHolding(s) in Company
16th Jun 20174:21 pmRNSHolding(s) in Company
16th Jun 20172:26 pmRNSHolding(s) in Company
15th Jun 20177:20 amRNSHolding(s) in Company
14th Jun 20179:08 amRNSDirector/PDMR Shareholding
13th Jun 20174:53 pmRNSHolding(s) in Company
13th Jun 20172:20 pmRNSDirector/PDMR Shareholding
5th Jun 20172:50 pmRNSHolding(s) in Company
1st Jun 20174:25 pmRNSHolding(s) in Company
30th May 20178:07 amRNSHolding(s) in Company
22nd May 20172:38 pmRNSHolding(s) in Company
22nd May 201711:49 amRNSHolding(s) in Company
18th May 20173:25 pmRNSHolding(s) in Company
17th May 20172:15 pmRNSHolding(s) in Company
16th May 201711:47 amRNSHolding(s) in Company
10th May 20177:38 amRNSDirector/PDMR Shareholding
8th May 20173:53 pmRNSHolding(s) in Company
4th May 20172:32 pmRNSHolding(s) in Company
4th May 201710:55 amRNS2017 AGM Results
4th May 20178:29 amRNSHolding(s) in Company
3rd May 201711:57 amRNSAGM Statement
28th Apr 201712:53 pmRNSDirector Declaration
18th Apr 20179:09 amRNSHolding(s) in Company
18th Apr 20177:30 amRNSDirector/PDMR Shareholding
13th Apr 201711:19 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSCarillion selected as preferred bidder
11th Apr 20174:19 pmRNSDirector/PDMR Shareholding
11th Apr 20174:13 pmRNSDirector/PDMR Shareholding
10th Apr 20177:00 amRNSCarillion JV awarded MoD contract
7th Apr 20174:14 pmRNSHolding(s) in Company
30th Mar 20178:07 amRNSHolding(s) in Company
29th Mar 20175:32 pmRNS2016 Annual Report & Accounts and 2017 AGM Notice
29th Mar 201712:37 pmRNSHolding(s) in Company
28th Mar 201712:25 pmRNSHolding(s) in Company
23rd Mar 20174:01 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSCarillion awarded £90m DIO contract in Cyprus
16th Mar 20178:28 amRNSHolding(s) in Company
16th Mar 20177:48 amRNSHolding(s) in Company
16th Mar 20177:46 amRNSHolding(s) in Company
14th Mar 20174:06 pmRNSHolding(s) in Company
3rd Mar 20179:25 amRNSJoint Venture awarded £490 million contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.